Can-Fite BioPharma Ltd. (CANF)

3.40 +0.89% (+0.03)

Over 6M: -30.0%

2026-08-28

Style

Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

3 4 5 6

Mar Apr May Jun Jul Aug

Financials Annual

Figures

Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›

-7.5M -5M -2.5M 0 2.5M

FY23 FY24 FY25

Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2025-12-31, reported in USD. The newest fact in the filings is dated 2025-12-31, 242 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6

SBC / sales 84.0%

Adj. EBITDA margin -2366.9%

Oper. margin -2456.8%

ROIC -12477.0%

Accruals -9.2%

Capex / sales 0.49%

Asset turnover 0.043×

EBITDA margin -2450.9%

FCF margin -2210.1%

OCF margin -2209.6%

ROA -103.3%

ROCE -146.7%

ROE -175.8%

Gross margin —

OCF / EBIT —

OE margin —

Profit margin —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5

Div. yield —

EV/EBIT —

EV/GP —

EV/OE —

EV/Sales —

FCF yield —

Fwd P/E —

P/B —

P/C —

P/E —

PEG —

Shareholder yield —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.5

RPO / sales 4.9×

Cash-flow margin stability 385.1 pp

Revenue growth in the worst year on record -39.9%

Prepaid revenue growth 0.0%

RPO growth 0.0%

Gross margin stability across years —

Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5

Current ratio 4.1×

ND/EBITDA —

Interest cover -35.0×

Debt / Eq 0.0×

Debt payback 0.0 yr

Equity / Assets 58.8%

Net debt / Eq 0.0×

Quick ratio 3.5×

Cash runway 0.62 yr

F-score 1.3 pts

Cash / Debt —

Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0

Most recent margin move -449.4

Operating margin trend -237.8

Sales CAGR 4Y -17.0%

Sales/sh Y/Y -73.5%

Div. growth +262.2%

Shares change +127.1%

EBIT CAGR —

EBIT Y/Y —

EPS CAGR 4Y —

EPS Y/Y —

EPS next Y —

Gross profit Y/Y —

Sales Q/Q —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.